Relationship Between Beta Cell Dysfunction and Severity of Disease Among Critically Ill Children: A STROBE-Compliant

Ping-Ping Liu1, Xiu-Lan Lu, Zheng-Hui Xiao

  • 1From the Emergency Center of Hunan Children's Hospital (P-PL, X-LL, Z-HX, JQ) and Pediatric Medical Center of Hunan People's Hospital (Y-MZ), Changsha, Hunan, China.

Medicine
|May 14, 2016
PubMed

Insights

Beta cell dysfunction in critically ill children is linked to increased disease severity and adverse outcomes. Assessing beta cell function is crucial for improving patient care in the Pediatric Intensive Care Unit (PICU).

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Beta cell dysfunction is a known prognostic factor in humans and animals.
  • Its predictive value for disease severity in critically ill children remains largely unexamined.

Purpose of the Study:

  • To investigate the association between beta cell dysfunction and disease severity in critically ill children.
  • To determine if beta cell function predicts adverse outcomes in this population.

Main Methods:

  • A prospective study of 1146 critically ill children admitted to the Pediatric Intensive Care Unit (PICU).
  • Beta cell function assessed using Homeostasis Model Assessment (HOMA)-β, categorizing patients into four groups.
  • Disease severity evaluated using Sequential Organ Failure Assessment (SOFA) and Pediatric Risk of Mortality (PRISM) III scores, and incidence of organ damage, septic shock, MODS, MV, and mortality.
  • Logistic regression analysis used to assess the risk of poor outcomes.

Main Results:

  • 70.41% of children exhibited HOMA-β < 100%.
  • Declining HOMA-β correlated with decreased C-peptide and insulin levels.
  • Higher SOFA and PRISM III scores were observed with declining HOMA-β.
  • Reduced beta cell function (lower HOMA-β) was associated with increased risk of septic shock, MODS, mechanical ventilation (MV), and mortality, even after adjusting for confounders.

Conclusions:

  • Beta cell dysfunction serves as an indicator of disease severity in critically ill children.
  • Assessment of beta cell function is vital for mitigating adverse events in the PICU.
  • This finding highlights the importance of monitoring metabolic status in pediatric critical care.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...